Medication info
Wimezol 40 mg (Esomeprazole Magnesium Trihydrate)

Wimezol 40 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
Seoheung Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets/ptp [14 tablets/PTP X 2]
Approval status
Active

MFDS item code 201901523 · Approved 2019.03.12

Summary

Main use
Treatment and prevention of acid-related disorders and ulcers; eradication therapy and prevention of rebleeding; relief of gastrointestinal symptoms caused by nonsteroidal anti-inflammatory drugs
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water. Do not chew or crush it. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. 6. Older adults: No dose adjustment is necessary.
Children's dosage
Adolescents 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. Children under 12 years: There is no experience with administration of this medicine to children under 12 years.

Ingredients

Manufacturer
Seoheung Co., Ltd.

Efficacy & effects

Treatment and prevention of acid-related disorders and ulcers; eradication therapy and prevention of rebleeding; relief of gastrointestinal symptoms caused by nonsteroidal anti-inflammatory drugs

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcer
  • peptic ulcer
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • rebleeding of gastric ulcer
View approved original text

This medicine is used for the treatment and symptom relief of gastroesophageal reflux disease and related esophagitis. It is also effective in the treatment of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection and in preventing recurrence. It is helpful in the treatment and prevention of gastric ulcers related to gastrointestinal symptoms that may occur when taking nonsteroidal anti-inflammatory drugs. It is used in the treatment of Zollinger-Ellison syndrome and is also utilized in the prevention and maintenance therapy of rebleeding of gastric or duodenal ulcers. In summary, this medicine is used for the treatment and prevention of various gastrointestinal diseases of the stomach and esophagus.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water. Do not chew or crush it. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. 6. Older adults: No dose adjustment is necessary.

Children's dosage

Adolescents 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. Children under 12 years: There is no experience with administration of this medicine to children under 12 years.

Precautions

This drug should not be administered to certain patients. It should not be used in patients with a known allergy or hypersensitivity to this drug, its components, or similar medications. Additionally, patients taking certain antibiotics or antiviral medications, those with a history of heart disease, and breastfeeding women should refrain from using this drug. Caution is necessary as various side effects may occur while taking this medication. Reported issues include blood-related problems, allergic reactions, electrolyte imbalances, mental symptoms, gastrointestinal symptoms, liver function abnormalities, and skin reactions. Symptoms like muscle pain or weakness may indicate severe muscle damage, necessitating immediate consultation with a physician. Long-term use of this medication may mask symptoms of malignant tumors, so if there are unusual symptoms like weight loss or vomiting, it is essential to discuss them with a physician. Regular health check-ups are important for long-term users. Also, this drug can reduce stomach acid, potentially increasing bacterial count in the gastrointestinal tract, raising the risk of infections, thus inform healthcare providers if diarrhea persists. Patients with osteoporosis or those at risk of fractures should be cautious, as long-term use may increase the risk of fractures. This drug may interact with other medications, so inform healthcare providers about all medications being taken, especially when combined with anticoagulants, antibiotics, and antivirals. Safety data on this drug during pregnancy is limited, so pregnant women should only use it after consulting a physician. Breastfeeding women should avoid this drug due to the possibility of it being transmitted through breast milk. There is no specific antidote for overdose, so appropriate treatment should be sought according to symptoms, and it should be stored out of the reach of children. Additionally, this drug should be stored in its original container to maintain its quality and not transferred to another container.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, retrosternal pain, facial swelling, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, thyroid swelling, irritable bowel syndrome, worsened constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disorder, pharyngeal disorder, rectal disorder, gastrointestinal symptoms, increased serum gastrin, tongue disorder, tongue swelling, ulcerative stomatitis, vomiting, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbated arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyositis, arthralgia, anorexia, apathy, increased appetite, confusion, worsened depression, generalized hypertonia, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, exacerbated migraine, sleep disorder, tremor, dizziness, visual field defect, paresthesia, drowsiness, dysmenorrhea, menstrual disorder, vaginitis, exacerbated asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, pruritus ani, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, altered smell, loss of taste, dysgeusia, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a sealed container. It is also important to maintain a temperature between 1°C and 30°C when storing the medication. This way, the medication can retain its effectiveness for a longer period.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets/ptp [14 tablets/PTP X 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.